Production (Stage)
Theravance Biopharma, Inc.
TBPH
$9.15
-$0.13-1.40%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 48.11% | -3.30% | -4.91% | -3.90% | -2.39% |
| Total Receivables | -77.57% | 306.29% | 17.81% | -2.49% | -16.08% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -5.17% | -48.31% | -7.35% | -7.51% | -29.22% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -6.71% | 38.28% | -2.37% | -4.01% | -6.92% |
|
|
|||||
| Total Current Assets | -6.71% | 38.28% | -2.37% | -4.01% | -6.92% |
| Net Property, Plant & Equipment | -3.67% | -3.64% | -7.10% | -9.36% | -2.81% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.98% | -22.31% | -0.13% | -0.08% | -0.08% |
| Total Assets | -2.99% | -0.55% | -1.64% | -2.50% | -2.80% |
|
|
|||||
| Total Accounts Payable | 7.40% | 54.20% | -13.14% | -0.71% | 10.63% |
| Total Accrued Expenses | -6.36% | 17.56% | 6.93% | 12.10% | -26.55% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.89% | 155.29% | -0.55% | 3.84% | 3.57% |
| Total Finance Division Other Current Liabilities | 0.00% | -9.82% | 0.00% | 0.00% | 0.00% |
| Total Other Current Liabilities | 0.00% | -9.82% | 0.00% | 0.00% | 0.00% |
| Total Current Liabilities | -1.82% | 36.91% | 2.13% | 5.93% | -12.54% |
|
|
|||||
| Total Current Liabilities | -1.82% | 36.91% | 2.13% | 5.93% | -12.54% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -4.50% | -4.11% | -3.90% | -3.19% | -3.09% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.23% | 1.12% | 3.18% | 2.00% | 1.96% |
| Total Liabilities | -0.57% | 4.79% | 1.25% | 1.14% | -1.52% |
|
|
|||||
| Common Stock & APIC | 0.35% | 0.48% | 0.41% | 0.47% | 0.31% |
| Retained Earnings | -1.41% | -1.63% | -1.35% | -1.80% | -1.28% |
| Treasury Stock & Other | -- | -86.00% | 327.27% | 46.34% | 36.92% |
| Total Common Equity | -5.45% | -5.45% | -4.15% | -5.46% | -3.82% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -5.45% | -5.45% | -4.15% | -5.46% | -3.82% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.45% | -5.45% | -4.15% | -5.46% | -3.82% |
|
|
|||||